Annotation Detail

Information
Associated Genes
ROS1
Associated Variants
ROS1 CD74-ROS1 G2032R
Associated Disease
lung non-small cell carcinoma
Source Database
CIViC Evidence
Description
Ba/F3 cells expressing CD74–ROS1 G2032R showed resistance to crizotinib, compared with those expressing wild-type CD74–ROS1 (~128 fold higher IC50); however, showed relative sensitivity to foretinib (only ~6 fold higher IC50 than WT).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1255
Gene URL
https://civic.genome.wustl.edu/links/genes/4941
Variant URL
https://civic.genome.wustl.edu/links/variants/465
Rating
2
Evidence Type
Predictive
Disease
Lung Non-small Cell Carcinoma
Evidence Direction
Supports
Drug
Foretinib
Evidence Level
D
Clinical Significance
Sensitivity/Response
Pubmed
25688157
Drugs
Drug NameSensitivitySupported
ForetinibSensitivitytrue